The largest database of trusted experimental protocols

Heparin sodium solution

Manufactured by Merck Group
Sourced in France, United States

Heparin sodium solution is a laboratory reagent used as an anticoagulant. It is a sterile, nonpyrogenic solution of heparin sodium, a naturally occurring substance that is extracted from porcine intestinal mucosa. The solution is intended for in vitro use in medical laboratories and research settings.

Automatically generated - may contain errors

4 protocols using heparin sodium solution

1

Baboon Endothelial Cell Thrombomodulation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Vacuum-pressed SIS was generously provided by Cook Biotech. Thrombomodulin, protein C, α-thrombin, and APC were from Haematologic Technologies. Heparin sodium solution was from Sigma Aldrich. Baboon platelet poor plasma from at least 5 animals was pooled using previously collected aliquots that had been stored at −80°C. The prothrombin time (PT) reagent Innovin® was purchased from Dade®, and the activated partial thromboplastin time (APTT) reagent HemosIL® was from Instrumentation Laboratories. The chromogenic substrate S-2366 used for APC quantification was from Chromogenix. Baboon carotid endothelial cells (ECs) were isolated as described previously [24 ][25 (link)]. Baboon ECs were cultured in endothelial growth medium-2 (EGM-2) from Lonza, supplemented with the MV BulletKit and 10% HyClone™ fetal bovine serum (FBS, GE Healthcare Life Sciences). Phosphate buffered saline (PBS) with Ca2+ and Mg2+ was from Mediatech, Inc.
+ Open protocol
+ Expand
2

siRNA Protection Against RNAse Degradation

Check if the same lab product or an alternative is used in the 5 most similar protocols
To analyze the siRNA protection against RNAse degradation, TS-MSN (at an initial siRNA concentration of 2.5 µM) were incubated with an aqueous ribonuclease A solution (1.2 µg/mL Sigma–Aldrich Chemie GmbH, Schelldorf, Germany) at a ratio of 2:1 for 30 min, 2, 4, and 6 h at 37 °C. Afterward, ribonuclease A was inactivated by heating the suspensions at 70 °C for 30 min. An equivalent amount of free siRNA was incubated for 30 min and used as a positive control to check the ribonuclease A activity to analyze the amount of free siRNA. Samples were diluted in water (Milli-Q system, Millipore, Paris, France) or aqueous heparin sodium solution (10 mg/mL) Sigma–Aldrich Chemie GmbH, Schnelldorf, Germany) and mixed with the loading buffer (agarose gel loading dye 6X) to deposit 20 mol ofsiRNA per well on 1% agarose gel containing ethidium bromide. With its strong negative charge, heparin is used as a control to displace complexed siRNA from TS-MSN. A 150 V voltage was applied for about 15 min in a Tris/acetate/EDTA buffer (TAE 1X, 40 mM acetate, EDTA 1 mM, pH 7.6). Gels were visualized and analyzed with EvolutionCapt software on a FusionSolo.65.WL imager (Vilbert Lourmat, Marne-la-Vallée, France).
+ Open protocol
+ Expand
3

Acute Copper Exposure: Blood and Liver Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The fish were anesthetized with MS-222 at a concentration of 60 mg/L before sampling. Two fish for each glass aquarium were sacrificed at 48 h after acute Cu exposure. Blood was collected from the caudal vein of fish using syringes previously infiltrated with heparin sodium solution (0.2%, Sigma, USA). Then, plasma was separated after a centrifugation at 3000 g for 15 min. Parts of livers were removed and fixed in 4% formaldehyde for liver histochemical and histological observations. The rest parts of liver were immediately dissected on ice and frozen in liquid nitrogen, storing in the refrigerator at -80°C until subsequent analysis.
+ Open protocol
+ Expand
4

Subcutaneous Islet Transplantation in Diabetic Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
Diabetes was rendered in recipient rats by a single intravenous injection of streptozotocin (STZ, 60 mg/kg, Sigma-Aldrich). Diabetes was confirmed by measuring blood glucose levels >400 mg/dl in two consecutive measurements. A prevascularized SC graft bed was prepared by implanting an agarose-basic fibroblast growth factor (bFGF) disc, as described [22 , 54 (link)]. Briefly, a lyophilized agarose disc made from 4.5% agarose solution (Sigma-Aldrich) with bFGF solution [500 μg/ml bFGF (Gold Biotechnology, St. Louis, MO) in saline] and heparin sodium solution [250 μg/ml (Sigma-Aldrich)] was implanted in the dorsal SC site of recipient rats. A week after implantation, a prevascularized capsule had formed around the disc, and the disc was removed through a small opening made on the capsule. Freshly isolated islets were used for SC transplantation. Islets loaded either on an O2 transporter (n=4) or Neg-CTL device (n=4) were transplanted into the space inside of the prevascularized capsule. The capsule opening and skin wound were separately sutured to close, except for the cannula portion of the device penetrating through the opening. These surgical procedures were performed under general anesthesia.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!